Inventor · disambiguated record
Scott Boyken
Also filed as: BOYKEN SCOTT · BOYKEN SCOTT EDWARD
6 granted patents·20 pending applications·3 citations·filing 2017–2024
71Inventor score
Top patents by PatentIndex Score
26 records- 0190US10851135B2De novo design of protein switchesUNIV WASHINGTON·Filed 2020·Granted Dec 1, 2020·3 cites·26 claims
- 0278US2025188125A1De novo Design of Protein SwitchesUNIV WASHINGTON·Filed 2024·Application pending·0 cites
- 0372US2024101615A1Orthogonal protein heterodimersUNIV WASHINGTON·Filed 2023·Application pending·0 cites
- 0470US2024409610A1Novel Recombinant Cell Surface MarkersLYELL IMMUNOPHARMA INC·Filed 2024·Application pending·0 cites
- 0569US2022098250A1Orthogonal protein heterodimersUNIV WASHINGTON·Filed 2021·Application pending·0 cites
- 0668US12304927B2De novo design of protein switchesUNIV WASHINGTON·Filed 2020·Granted May 20, 2025·0 cites·10 claims
- 0765US11820800B2Orthogonal protein heterodimersUNIV WASHINGTON·Filed 2019·Granted Nov 21, 2023·0 cites·10 claims
- 0863US12054531B2Recombinant cell surface markersLYELL IMMUNOPHARMA INC·Filed 2021·Granted Aug 6, 2024·0 cites·28 claims
- 0963US2024029824A1De novo design of obligate ABC heterotrimeric proteinsUNIV WASHINGTON·Filed 2023·Application pending·0 cites
- 1061US12144827B2ROR1 targeting chimeric antigen receptorLYELL IMMUNOPHARMA INC·Filed 2022·Granted Nov 19, 2024·0 cites·20 claims
- 1156US2021380658A1Chimeric antigen receptor spacersLYELL IMMUNOPHARMA INC·Filed 2021·Application pending·0 cites
- 1256US2025011399A1Chimeric antigen receptorsOUTPACE BIO INC·Filed 2022·Application pending·0 cites
- 1355US2025223330A1Designed cytokine compositions and methods of useOUTPACE BIO INC·Filed 2023·Application pending·0 cites
- 1454US2022017579A1Orthogonal protein heterodimersUNIV WASHINGTON·Filed 2021·Application pending·0 cites
- 1553US2023250134A1SARS-COV-2 inhibitorsUNIV WASHINGTON·Filed 2021·Application pending·0 cites
- 1653US2023159615A1Chimeric polypeptidesOUTPACE BIO INC·Filed 2022·Application pending·0 cites
- 1751US2025268938A1Small molecule-regulated cell signaling expression systemOUTPACE BIO INC·Filed 2022·Application pending·0 cites
- 1850US2021101945A1Polypeptides Capable of Forming Homo-Oligomers with Modular Hydrogen Bond Network-Mediated Specificity and Their DesignUNIV WASHINGTON·Filed 2020·Application pending·0 cites
- 1949US2022218752A1Lockr-mediated recruitment of car t cellsUNIV WASHINGTON·Filed 2020·Application pending·0 cites
- 2049US2022226485A1De novo design of phosphorylation inducible protein switches (phospho-switches)UNIV WASHINGTON·Filed 2020·Application pending·0 cites
- 2148US2022273711A1Ultraspecific Cell Targeting Using De Novo Designed Co-Localization Dependent Protein SwitchesUNIV WASHINGTON·Filed 2020·Application pending·0 cites
- 2246US2022185853A1Amantadine binding proteinUNIV WASHINGTON·Filed 2020·Application pending·0 cites
- 2344US10988514B2Polypeptdes capable of forming homo-oligomers with modular hydrogen bond network-mediated specificity and their designUNIV WASHINGTON·Filed 2017·Granted Apr 27, 2021·0 cites·21 claims
- 2444US2022144895A1De novo design of tunable ph-driven conformational switchesUNIV WASHINGTON·Filed 2020·Application pending·0 cites
- 2544US2022073565A1De novo design of protein switches for tunable control of protein degradationUNIV WASHINGTON·Filed 2020·Application pending·0 cites
- 2642US2021363214A1Transmembrane polypeptidesUNIV WASHINGTON·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Scott Boyken files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →